GlassScriptPhysician profile
Barbara J Smith
NPI 1235557851
$3,218.06
in general payments reported to CMS, 2019-2025
26 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,277 · 2022: $1,138 · 2023: $212 · 2024: $231 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $451.04 | 2021-2024 | Xarelto |
| W. L. Gore & Associates, INC. | $305.69 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Amgen INC. | $250.05 | 2021-2025 | Repatha |
| Boston Scientific Corporation | $216.06 | 2021-2024 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $204.57 | 2021-2022 | |
| Abbott Laboratories | $189.98 | 2021-2022 | |
| Pfizer INC. | $159.35 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.99 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $151.40 | 2021-2023 | Verquvo |
| Biotronik INC. | $144.70 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $139.38 | 2021-2022 | |
| Astellas Pharma US INC | $127.67 | 2021 | |
| Glaxosmithkline, LLC. | $125.00 | 2021 | |
| Cvrx, INC. | $122.89 | 2023 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $112.49 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $87.09 | 2022-2023 | Onpattro |
| Chiesi USA, INC. | $46.74 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.35 | 2021 | |
| Amarin Pharma, INC. | $42.21 | 2021 | |
| Esperion Therapeutics, INC. | $34.00 | 2021 | |
| Surmodics, INC. | $27.02 | 2025 | Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy System |
| Lantheus Medical Imaging, INC. | $19.32 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.83 | 2022 | |
| Medtronic, INC. | $15.47 | 2021 | |
| Medicomp INC | $13.26 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.